Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway

doi:10.3748/wjg.v29.i31.4744

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 31

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4662)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-9) series.

Item

Count

PDF

WORD

HTML

2257

Figures (1-9)

514

Sum=2899

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

137

Download

579

Sum=716

Publishing Process of This Article

Item

Count

Browse

187

Download

699

Sum=886

Aug 21, 2023 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Aug 21, 2023; 29(31): 4744-4762
Published online Aug 21, 2023. doi: 10.3748/wjg.v29.i31.4744

Full Size Figure Download Figure

Figure 1 High-performance liquid chromatography fingerprint spectrum of Huangqin decoction and structures of the major phytochemicals in Huangqin decoction. A and B: High-performance liquid chromatography profiles of Huangqin decoction (HQD) and the standard mixture: (1) Gallic acid, (2) paeoniflorin, (3) scutellarin, (4) liquiritin, (5) baicalin, (6) scutellarein, (7) wogonoside, (8) baicalein, (9) wogonin, and (10) chrysin; C: Structures of the major phytochemicals in HQD.

Citation: Yan BF, Pan LF, Quan YF, Sha Q, Zhang JZ, Zhang YF, Zhou LB, Qian XL, Gu XM, Li FT, Wang T, Liu J, Zheng X. Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway. World J Gastroenterol 2023; 29(31): 4744-4762
URL: https://www.wjgnet.com/1007-9327/full/v29/i31/4744.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i31.4744